Stocks · Health care · Pharmaceutical Preparations

MBX Biosciences, Inc.

MBX Clue Score38
United States Fiscal year ends December CIK 0001776111 Results filed 6 Aug 2026

What the insiders did Net selling

By person

9 insiders · 1 transaction
104×

P. Kent Hawryluk holds 104 times base salary in stock. $65.53M of shares against $625.00K in salary for 2025.

Salary from the company's own proxy. The shares are what P. Kent Hawryluk last reported holding, valued at $53.96, the price Common Stock was last bought or sold at on the open market here, on 4 Nov 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Salomon Azoulay
Chief Medical Officer
—
$20.13K (1)
−$20.13K
14,026
0.0291%
$756.84K
—
Patrick J Heron
Director
—
—
—
5,219,440
10.84%
$281.64M
+14.6%
P. Kent Hawryluk
President & CEO
—
—
—
1,214,444
2.52%
$65.53M
+38.1%
Orbimed Advisors LLC entity
Director
—
—
—
747,887
1.55%
$40.36M
+34.2%
Carl L Gordon
Director
—
—
—
747,887
1.55%
$40.36M
+34.2%
Steven L. Hoerter
President and CEO
—
—
—
102,938
0.2137%
$5.55M
—
John W Smither
Chief Financial Officer
—
—
—
28,000
0.0581%
$1.51M
—
Ora H. Pescovitz
Director
—
—
—
24,329
0.0505%
$1.31M
+46.2%
Richard Bartram
Chief Financial Officer
—
—
—
15,000
0.0311%
$809.40K
—